Literature DB >> 15724419

[The heart and aerobatics].

E Perrier1, P A Leduc, O Manen, M Lerecouvreux, J Deroche, J F Paris, Ph Doireau, G Quiniou, S Geffroy, R Carlioz.   

Abstract

Aerobatics is an aerial sport which has many physiological constraints, principally cardiovascular, with a risk if not adapted of sudden mid-air incapacity which could jeopardise aviation safety, and thus justifies the selection and surveillance of pilots. The aeronautical constraints during flight are multiple, related to the environment traversed, how the aircraft functions and its movements. Those which cause accelerations (+G in particular) pose the problem of haemodynamic tolerance because they can induce loss of consciousness due to cerebral hypoxia. Tolerance of acceleration varies among individuals; it can be improved with training, certain protective manoeuvres, and is reduced by hypoxia, certain medications, dehydration and heat. Moreover, in aerobatics certain tricks require manoeuvres which reduce this tolerance to +G accelerations. This is the "push-pull" effect (_G acceleration immediately followed by +G acceleration). This leads to a risk of sudden loss of consciousness with a load factor much lower than that which the pilot knows he is capable of tolerating. Besides the haemodynamic effects, the existence of an actual acceleration cardiomyopathy has been suggested but has not been proven in man. Finally, while changes in cardiac rhythm during accelerations are usual and relate to changes in vaso-sympathetic balance, ventricular and supra-ventricular rhythm disturbances are rare and are related to the intensity and duration of the acceleration.

Entities:  

Mesh:

Year:  2005        PMID: 15724419

Source DB:  PubMed          Journal:  Arch Mal Coeur Vaiss        ISSN: 0003-9683


  1 in total

1.  Effects of positive acceleration (+Gz stress) on liver enzymes, energy metabolism, and liver histology in rats.

Authors:  Bin Shi; Xian-Qiang Wang; Wei-Dong Duan; Guo-Dong Tan; Han-Jing Gao; Ying-Wei Pan; Qing-Jun Guo; Hong-Yi Zhang
Journal:  World J Gastroenterol       Date:  2019-01-21       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.